Samyang Foods Breaks Ground on First Overseas Production Plant in China

Reporter Kim Jisun / approved : 2025-07-04 03:32:44
  • -
  • +
  • 인쇄

 

 

[Alpha Biz= Kim Jisun] Samyang Foods, the company behind the global hit Buldak Ramen, held a groundbreaking ceremony on July 3 for its first overseas production facility in Jiaxing, Zhejiang Province, China.



The Jiaxing plant will span 55,043 square meters of land with a total floor area of 58,378 square meters across three above-ground floors. It will house six production lines, with a total investment of KRW 201.4 billion (approx. USD 145 million). Completion is scheduled for January 2027.



Once operational, the factory is expected to produce up to 840 million units of Buldak Ramen annually, all of which will be supplied to the domestic Chinese market. Samyang Foods aims to enhance its localization strategy through product development tailored to Chinese consumer preferences and targeted marketing initiatives.



With the addition of the Jiaxing plant, Samyang Foods will operate five production bases in total, including existing facilities in Wonju, Iksan, and Miryang in South Korea. The company’s total annual production capacity for Buldak Ramen will increase to approximately 3.52 billion units.



Samyang also plans to implement international quality management standards at the new site. It aims to obtain certifications such as FSSC 22000 (Food Safety System Certification), ISO 22000 (Food Safety Management), and ISO 14001 (Environmental Management), all recognized by the Global Food Safety Initiative (GFSI).

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

NAVER Secures 60,000 NVIDIA Blackwell GPUs to Lead Industrial AI Innovation2025.11.01
Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사